scholarly journals Dasatinib, nilotinib and standard-dose imatinib for the first-line treatment of chronic myeloid leukaemia: systematic reviews and economic analyses.

2012 ◽  
Vol 16 (42) ◽  
Author(s):  
T Pavey ◽  
M Hoyle ◽  
O Ciani ◽  
L Crathorne ◽  
T Jones-Hughes ◽  
...  
Keyword(s):  
Chronic Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
Systematic Reviews ◽  
Standard Dose ◽  
Line Treatment ◽  
First Line ◽  
Economic Analyses ◽  
First Line Treatment

scholarly journals Clinical Profile and Response to First Line Treatment in Chronic Phase of Chronic Myeloid Leukaemia

2020 ◽  
Vol 9 (52) ◽  
pp. 3973-3976
Author(s):  
Sivasubramaniam K. ◽  
Latha K. V.S. ◽  
Abhishek R. ◽  
Niranjan V. ◽  
Tintu M.V ◽  
...  
Keyword(s):  
Chronic Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
Chronic Phase ◽  
Clinical Profile ◽  
Line Treatment ◽  
First Line ◽  
First Line Treatment

scholarly journals Ponatinib as first-line treatment for patients with chronic myeloid leukaemia in chronic phase: a phase 2 study

2015 ◽  
Vol 2 (9) ◽  
pp. e376-e383 ◽  
Author(s):  
Preetesh Jain ◽  
Hagop Kantarjian ◽  
Elias Jabbour ◽  
Graciela Nogueras Gonzalez ◽  
Gautam Borthakur ◽  
...  
Keyword(s):  
Chronic Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
Chronic Phase ◽  
Line Treatment ◽  
Phase 2 ◽  
First Line ◽  
Phase 2 Study ◽  
First Line Treatment
Sign in / Sign up

Export Citation Format

Share Document